Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Saite Pharmaceutical is a China-based pharmaceutical company specializing in the research, development, and manufacturing of active pharmaceutical ingredients (APIs) and finished dosage forms. The company focuses primarily on cardiovascular and metabolic health, with a strong portfolio of statins and antihypertensive medications. Operating out of Huzhou, Zhejiang, it maintains high-standard manufacturing facilities compliant with global GMP regulations. Saite Pharmaceutical serves both domestic and international markets through its integrated production capabilities. Their product line includes widely used treatments such as Atorvastatin, Rosuvastatin, and various Angiotensin II receptor blockers. The company is recognized for its expertise in complex chemical synthesis and large-scale API production.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Saite Pharmaceutical.